Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03410927
Recruitment Status : Active, not recruiting
First Posted : January 25, 2018
Last Update Posted : December 20, 2021
Information provided by (Responsible Party):
Taiho Oncology, Inc.